Angle PLC Holding(s) in Company (4527B)
April 04 2017 - 2:01AM
UK Regulatory
TIDMAGL
RNS Number : 4527B
Angle PLC
04 April 2017
For immediate release 4 April 2017
ANGLE plc ("the Company")
Holding(s) in Company
The Company has been informed by Lombard Odier Investment
Managers group ("Lombard") that, following its recent acquisition
of Henderson Volantis from Henderson Global plc ("Henderson"),
Lombard has acquired ordinary shares in the Company via an
in-specie transfer of accounts managed by Henderson on a
discretionary basis to Lombard. Further information is set out
below.
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or ANGLE Plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
------------------------------------------------------------- ----------------------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
-------------------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
---------------------------------------------------------------------------------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
---------------------------------------------------------------------------------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
---------------------------------------------------------------------------------------------------------
An event changing the breakdown of voting rights
---------------------------------------------------------------------------------------------------------
Other (please Transfer of accounts managed on a X
specify): discretionary basis by Henderson Group
Plc to Lombard Odier Investment Managers
group
--------------------------------------------------------- ----------------------------------------------
3. Full name of person(s) Lombard Odier Asset Management
subject to the (Europe) Limited
notification obligation:
(iii)
----------------------------------------------------------- ------------------------------------------------
4. Full name of shareholder(s) Disclosure on behalf of accounts
(if different from 3.):(iv) managed on a discretionary
basis by Lombard Odier Investment
Managers group.
----------------------------------------------------------- ------------------------------------------------
5. Date of the transaction 01/04/2017
and date on
which the threshold is
crossed or
reached: (v)
----------------------------------------------------------- ------------------------------------------------
6. Date on which issuer 03/04/2017
notified:
----------------------------------------------------------- ------------------------------------------------
7. Threshold(s) that is/are above 5%
crossed or
reached: (vi, vii)
----------------------------------------------------------- ------------------------------------------------
8. Notified details:
---------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
---------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
-------------- ------------------------------ ---------------------------------------------------------
Number Number Number Number of % of voting
of of of shares voting rights (x)
Shares Voting rights
Rights
-------------- -------------- -------------- ------------- --------------------- -------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
-------------- ------------ ------------ ------------- --------- ---------- -------- ---------
GB0034330679 5,899,164 7.88%
---------- -------- ---------
B: Qualifying Financial Instruments
---------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
---------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
---------------- ------------- ----------------------------- -------------------- -------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
---------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
---------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
--------------- ------------- ------------- -------------- --------------------- -------------------
Nominal Delta
--------------- ------------- ------------- -------------- --------------------- -------- ---------
Total (A+B+C)
---------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
----------------------------------------------- --------------------------------------------------------
5,899,164 7.88%
----------------------------------------------- --------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
--------------------------------------------------------------------------------
Proxy Voting:
--------------------------------------------------------------------------------
10. Name of the proxy holder:
------------------------------------------------------------- -----------------
11. Number of voting rights proxy
holder will cease to hold:
------------------------------------------------------------- -----------------
12. Date on which proxy holder will
cease to hold
voting rights:
------------------------------------------------------------- -----------------
13. Additional information:
------------------------------------------------------------- -----------------
14. Contact name: Kiran Bassi
------------------------------------------------------------- -----------------
15. Contact telephone number: +44 20 3206 6000
------------------------------------------------------------- -----------------
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or ANGLE Plc
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
------------------------------------------------------------- ---------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
--------------------------------------------------------------------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
--------------------------------------------------------------------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
--------------------------------------------------------------------------------------
An event changing the breakdown of voting rights
--------------------------------------------------------------------------------------
Other (please In specie transfer out X
specify):
--------------------------------------------------------- ---------------------------
3. Full name of person(s) Henderson Group plc
subject to the
notification obligation:
(iii)
----------------------------------------------------------- -----------------------------
4. Full name of shareholder(s)
(if different from 3.):(iv)
----------------------------------------------------------- -----------------------------
5. Date of the transaction 31 March 2017
and date on
which the threshold is
crossed or
reached: (v)
----------------------------------------------------------- -----------------------------
6. Date on which issuer 3 April 2017
notified:
----------------------------------------------------------- -----------------------------
7. Threshold(s) that is/are Below 5%
crossed or
reached: (vi, vii)
----------------------------------------------------------- -----------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
----------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
-------------- -------------------------- --------------------------------------------------------
Number Number Number Number of % of voting
of of of voting rights (x)
Shares Voting shares rights
Rights
-------------- ------------ ------------ ------------ --------------------- -------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
-------------- ------------ ------------ ------------ ------- ------------ -------- ---------
Below Below
Ordinary 4,205,074 4,205,074 5% 5%
------------ ------------ ------------ ------- ------------ -------- ---------
GB0034330679
-------------- ------------ ------------ ------------ ------- ------------ -------- ---------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
-------------- ------------ -------------------------- --------------------- -------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights (xix,
instrument (xvii) period refers to xx)
(xviii)
-------------- ------------ ------------ ------------ --------------------- -------------------
Nominal Delta
-------------- ------------ ------------ ------------ --------------------- -------- ---------
Total (A+B+C)
----------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------------------------ --------------------------------------------------------
Below 5% Below 5%
------------------------------------------ --------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
-----------------------------------------------------------------------------------------------------
See Annex 1 below.
Proxy Voting:
-----------------------------------------------------------------------------------------------------
10. Name of the proxy holder:
------------------------------------------------------------- --------------------------------------
11. Number of voting rights proxy
holder will cease to hold:
------------------------------------------------------------- --------------------------------------
12. Date on which proxy holder will
cease to hold voting rights:
------------------------------------------------------------- --------------------------------------
13. Additional information:
------------------------------------------------------------- --------------------------------------
14. Contact name: HGIThresholdDisclosures@henderson.com
------------------------------------------------------------- --------------------------------------
15. Contact telephone number: 020 7818 1818
------------------------------------------------------------- --------------------------------------
Annex 1: Information in relation to the person subject
to the notification obligation (please tick the applicable
box):
[ ] Person subject to the notification obligation is
not controlled by any natural person or legal entity
and does not control any other undertaking(s) holding
directly or indirectly an interest in the (underlying)
issuer.(xiii)
[X] Full chain of controlled undertakings through which
the voting rights and/or the
financial instruments are effectively held starting
with the ultimate controlling natural person or legal
entity(xiv) :
Name(xv) % of voting % of voting Total of both
rights if it rights through if it equals
equals or is financial instruments or is higher
higher than if it equals than the notifiable
the notifiable or is higher threshold
threshold than the notifiable
threshold
---------------------- ---------------- ----------------------- ---------------------
Henderson Group Below 5% - Below 5%
plc, Henderson
Group Holdings
Asset Management
Limited, HGI
Asset Management
Group Limited,
Henderson Global
Group Limited,
Henderson Holdings
Group Limited,
HGI Group Limited,
Henderson Global
Investors (Holdings)
Limited, AlphaGen
Capital Limited
---------------------- ---------------- ----------------------- ---------------------
Henderson Group Below 5% - Below 5%
plc, Henderson
Group Holdings
Asset Management
Limited, HGI
Asset Management
Group Limited,
Henderson Global
Group Limited,
Henderson Holdings
Group Limited,
HGI Group Limited,
Henderson Global
Investors (Holdings)
Limited, Henderson
Global Investors
Limited
---------------------- ---------------- ----------------------- ---------------------
For further information:
ANGLE plc 01483 685830
Andrew Newland, Chief Executive
Ian Griffiths, Finance Director
Cenkos Securities
Stephen Keys (Nominated adviser),
Steve Cox
Russell Kerr (Sales) 020 7397 8900
WG Partners
David Wilson
Claes Spång 020 3705 9330
FTI Consulting
Simon Conway, Mo Noonan,
Stephanie Cuthbert 020 3727 1000
Kimberly Ha (US) 001 212 850 5612
For Frequently Used Terms, please see the Company's website on
http://www.angleplc.com/the-parsortix-system/glossary/
Notes for editors
About ANGLE plc www.angleplc.com
ANGLE is a specialist medtech company commercialising a
disruptive platform technology that can capture cells circulating
in blood, such as cancer cells, even when they are as rare in
number as one cell in one billion blood cells, and harvest the
cells for analysis.
ANGLE's cell separation technology is called the Parsortix(TM)
system and it enables a liquid biopsy (simple blood test) to be
used to provide the cells of interest. Parsortix is the subject of
granted patents in Europe, the United States, Canada, China, Japan
and Australia and three extensive families of patents are being
progressed worldwide. The system is based on a microfluidic device
that captures live cells based on a combination of their size and
compressibility. Parsortix has a CE Mark for Europe and FDA
authorisation is in process for the United States.
ANGLE has established formal collaborations with world-class
cancer centres. These Key Opinion Leaders are working to identify
applications with medical utility (clear benefit to patients), and
to secure clinical data that demonstrates that utility in patient
studies. Details are available here
http://www.angleplc.com/the-company/collaborators/
The analysis of the cells that can be harvested from patient
blood with ANGLE's Parsortix system has the potential to help
deliver personalised cancer care offering profound improvements in
clinical and health economic outcomes in the treatment and
diagnosis of various forms of cancer.
The global increase in cancer to a 1 in 3 lifetime incidence is
set to drive a multi-billion dollar clinical market. The Parsortix
system is designed to be compatible with existing major medtech
analytical platforms and to act as a companion diagnostic for major
pharma in helping to identify patients that will benefit from a
particular drug and then monitoring the drug's effectiveness.
As well as cancer, the Parsortix technology has the potential
for deployment with several other important cell types in the
future.
ANGLE stock trades on the AIM market of the London Stock
Exchange under the ticker symbol AGL and in New York on the OTC-QX
under the ticker symbol ANPCY. For further information please
visit: www.angleplc.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLIJMBTMBMMTIR
(END) Dow Jones Newswires
April 04, 2017 02:01 ET (06:01 GMT)
Angle (LSE:AGL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Angle (LSE:AGL)
Historical Stock Chart
From Apr 2023 to Apr 2024
